 | • レポートコード：MRC2012A5757 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、はしか・おたふく風邪・風疹ウイルス用ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。はしか・おたふく風邪・風疹ウイルス用ワクチンの種類別市場規模（子供、大人）、用途別市場規模（公共、個人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Lanzhou Institute、Tiantan Bio、Minhai Bio、Beijing Bio-Institute、 ・地域別グローバル市場分析 2015年-2020年 ・はしか・おたふく風邪・風疹ウイルス用ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・はしか・おたふく風邪・風疹ウイルス用ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・はしか・おたふく風邪・風疹ウイルス用ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・はしか・おたふく風邪・風疹ウイルス用ワクチンの南米市場（ブラジル、アルゼンチン） ・はしか・おたふく風邪・風疹ウイルス用ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：子供、大人 ・用途別分析：公共、個人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Measles, Mumps, and Rubella Virus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Measles, Mumps, and Rubella Virus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Measles, Mumps, and Rubella Virus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Measles, Mumps, and Rubella Virus Vaccine market has been segmented into
Child
Adult
By Application, Measles, Mumps, and Rubella Virus Vaccine has been segmented into:
Public
Private
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Measles, Mumps, and Rubella Virus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Measles, Mumps, and Rubella Virus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Measles, Mumps, and Rubella Virus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Measles, Mumps, and Rubella Virus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Measles, Mumps, and Rubella Virus Vaccine Market Share Analysis
Measles, Mumps, and Rubella Virus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Measles, Mumps, and Rubella Virus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Measles, Mumps, and Rubella Virus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Measles, Mumps, and Rubella Virus Vaccine are:
Merck
Lanzhou Institute
Tiantan Bio
Minhai Bio
Beijing Bio-Institute
Among other players domestic and global, Measles, Mumps, and Rubella Virus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles, Mumps, and Rubella Virus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Measles, Mumps, and Rubella Virus Vaccine, with price, sales, revenue and global market share of Measles, Mumps, and Rubella Virus Vaccine in 2018 and 2019.
Chapter 3, the Measles, Mumps, and Rubella Virus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles, Mumps, and Rubella Virus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Measles, Mumps, and Rubella Virus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Measles, Mumps, and Rubella Virus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Measles, Mumps, and Rubella Virus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Child
1.2.3 Adult
1.3 Market Analysis by Application
1.3.1 Overview: Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public
1.3.3 Private
1.4 Overview of Global Measles, Mumps, and Rubella Virus Vaccine Market
1.4.1 Global Measles, Mumps, and Rubella Virus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lanzhou Institute
2.2.1 Lanzhou Institute Details
2.2.2 Lanzhou Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lanzhou Institute SWOT Analysis
2.2.4 Lanzhou Institute Product and Services
2.2.5 Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Tiantan Bio
2.3.1 Tiantan Bio Details
2.3.2 Tiantan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Tiantan Bio SWOT Analysis
2.3.4 Tiantan Bio Product and Services
2.3.5 Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Minhai Bio
2.4.1 Minhai Bio Details
2.4.2 Minhai Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Minhai Bio SWOT Analysis
2.4.4 Minhai Bio Product and Services
2.4.5 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Beijing Bio-Institute
2.5.1 Beijing Bio-Institute Details
2.5.2 Beijing Bio-Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Beijing Bio-Institute SWOT Analysis
2.5.4 Beijing Bio-Institute Product and Services
2.5.5 Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Measles, Mumps, and Rubella Virus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Measles, Mumps, and Rubella Virus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2015-2020)
11 Global Measles, Mumps, and Rubella Virus Vaccine Market Segment by Application
11.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Measles, Mumps, and Rubella Virus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025)
12.2.4 South America Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025)
12.3 Measles, Mumps, and Rubella Virus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Measles, Mumps, and Rubella Virus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Measles, Mumps, and Rubella Virus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Measles, Mumps, and Rubella Virus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Measles, Mumps, and Rubella Virus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Measles, Mumps, and Rubella Virus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Measles, Mumps, and Rubella Virus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Measles, Mumps, and Rubella Virus Vaccine Major Business
Table 9. Merck Measles, Mumps, and Rubella Virus Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 12. Merck Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 14. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Major Business
Table 15. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Lanzhou Institute SWOT Analysis
Table 17. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 18. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Major Business
Table 21. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Tiantan Bio SWOT Analysis
Table 23. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 24. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Minhai Bio Basic Information, Manufacturing Base and Competitors
Table 26. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Major Business
Table 27. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Minhai Bio SWOT Analysis
Table 29. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 30. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Beijing Bio-Institute Basic Information, Manufacturing Base and Competitors
Table 32. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Major Business
Table 33. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Beijing Bio-Institute SWOT Analysis
Table 35. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 36. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Regions (2015-2020) (K Units)
Table 40. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Regions (2015-2020)
Table 41. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Countries (2015-2020) (K Units)
Table 43. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries (2015-2020)
Table 44. North America Measles, Mumps, and Rubella Virus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries (2015-2020)
Table 46. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Countries (2015-2020) (K Units)
Table 47. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries (2015-2020)
Table 48. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Measles, Mumps, and Rubella Virus Vaccine Sales by Countries (2015-2020) (K Units)
Table 53. South America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries (2015-2020)
Table 54. South America Measles, Mumps, and Rubella Virus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries (2015-2020)
Table 60. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2015-2020) (K Units)
Table 61. Global Measles, Mumps, and Rubella Virus Vaccine Sales Share by Type (2015-2020)
Table 62. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 63. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Share by Type (2015-2020)
Table 64. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2015-2020) (K Units)
Table 65. Global Measles, Mumps, and Rubella Virus Vaccine Sales Share by Application (2015-2020)
Table 66. Global Measles, Mumps, and Rubella Virus Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Measles, Mumps, and Rubella Virus Vaccine Market Share Forecast by Regions (2021-2025)
Table 68. Global Measles, Mumps, and Rubella Virus Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Measles, Mumps, and Rubella Virus Vaccine Market Share Forecast by Type (2021-2025)
Table 70. Global Measles, Mumps, and Rubella Virus Vaccine Sales Forecast by Application (2021-2025)
Table 71. Global Measles, Mumps, and Rubella Virus Vaccine Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Measles, Mumps, and Rubella Virus Vaccine Picture
Figure 2. Global Sales Market Share of Measles, Mumps, and Rubella Virus Vaccine by Type in 2019
Figure 3. Child Picture
Figure 4. Adult Picture
Figure 5. Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application in 2018
Figure 6. Public Picture
Figure 7. Private Picture
Figure 8. Global Measles, Mumps, and Rubella Virus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Measles, Mumps, and Rubella Virus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Measles, Mumps, and Rubella Virus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Measles, Mumps, and Rubella Virus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Regions 2019
Figure 61. China Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Measles, Mumps, and Rubella Virus Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Measles, Mumps, and Rubella Virus Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
流行性耳下腺炎ウイルス検査の世界市場（～2026年） Mumps is a contagious disease which affects children as well as adult and it is caused by the mumps virus. Mumps is a type of viral infection that affects the parotid gland which one of the member of saliva producing gland. The swelling in one or both parotid gland is the indication for the mumps. T…- 水痘ウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Varicella Virus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Varicella Virus Vacci…
- 水痘生ウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Varicella Virus Vaccine Live market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Varicella Virus …
- 日本脳炎ウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis Virus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese …
- ウイルス診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Virus Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…